Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report

被引:42
|
作者
Endo, Beatriz [1 ,2 ]
Bahamon, Silvana [1 ,2 ]
Martinez-Pulgarin, Dayron F. [2 ]
机构
[1] Clin Oftalmol Cali, Dept Retina, Cali 760036, Colombia
[2] Pontificia Univ Javeriana Cali, Vitreoretinal Fellowship Program, Cali, Colombia
关键词
CRVO; COVID-19; SARS-Cov2; vaccine;
D O I
10.4103/ijo.IJO_1477_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
A central retinal vein occlusion (CRVO) case in a patient developed with sudden blurred vision in some hemifield areas of his left eye, maintaining 20/20 vision 15-days after the COVID-19 vaccination. Initial retinal findings were venous dilation and tortuosity with dispersing dot hemorrhages. Fluorescein angiography (FA) and optical coherence tomography (OCT) confirmed a non-ischemic CRVO diagnosis, and a complete blood panel was requested with average results. An intravitreal steroid dose was applied. A decrease in best-corrected visual acuity (BCVA) (20/30) with more intraretinal hemorrhages was documented. An intravitreal dose of bevacizumab and oral apixaban were added with a final BCVA of 20/20 with decreased hemorrhages. There is no specific causal relationship between COVID-19 vaccines and CRVO. Without previous risk factors and positive treatment response, this case may correlate the first COVID-19 vaccine dose and the event.
引用
收藏
页码:2865 / 2866
页数:2
相关论文
共 50 条
  • [41] Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions
    Eren, Ozan E.
    Tonon, Matthias
    Schoeberl, Florian
    Giessen-Jung, Clemens
    Moosmann, Andreas
    Hollaus, Alexandra
    Muenchhoff, Maximilian
    Dimitriadis, Konstantinos
    INFECTION, 2021, 49 (04) : 785 - 788
  • [42] Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased
    Diebold, Matthias
    Locher, Eleonore
    Boide, Philipp
    Enzler-Tschudy, Annette
    Faivre, Anna
    Fischer, Ingeborg
    Helmchen, Birgit
    Hopfer, Helmut
    Kim, Min Jeong
    Moll, Solange
    Nanchen, Giliane
    Rotman, Samuel
    Saganas, Charalampos
    Seeger, Harald
    Kistler, Andreas D.
    KIDNEY INTERNATIONAL, 2022, 102 (06) : 1409 - 1419
  • [43] Should we continue breastfeeding after SARS-CoV-2 infection or mRNA vaccination?
    Chen, Fei
    Luan, Chun
    Wei, Zichun
    Cai, Dechen
    Cui, Zhiwen
    Li, Yuyang
    Wu, Hao
    Zhang, Xiaoxia
    Wu, Xiaoli
    BIOCELL, 2022, 46 (06) : 1425 - 1433
  • [44] Deep vein thrombosis during vaccination against SARS-CoV-2 period
    Pastor Alconchel, Laura
    Ki Yoo, Young Woon
    Escolano Gonzalez, Laura
    Garcia Nieto, Beatriz
    Hidalgo Iranzo, Noemi
    Marzo Alvarez, Ana Cristina
    ANGIOLOGIA, 2023, 75 (01): : 11 - 18
  • [45] Pilomatricoma Growing at the SARS-CoV-2 mRNA Vaccination Site
    Erkayman, Merve Hatun
    Guven, Melike
    Bingol, Merve
    Bulut, Numan
    Demirtas, Rabia
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (05)
  • [46] Prevalence of SARS-CoV-2 among central retinal artery occlusion patients: A case series-HORA study report No. 3
    Sunny, Chi Lik Au
    Callie, Ka Li Ko
    JOURNAL OF ACUTE DISEASE, 2021, 10 (04) : 147 - 149
  • [47] Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
    Romano, Emanuela
    Pascolo, Steve
    Ott, Patrick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [48] Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions
    Ozan E. Eren
    Matthias Tonon
    Florian Schöberl
    Clemens Gießen-Jung
    Andreas Moosmann
    Alexandra Hollaus
    Maximilian Muenchhoff
    Konstantinos Dimitriadis
    Infection, 2021, 49 : 785 - 788
  • [49] SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
    Fernando Garcia-Cruces-Mendeza, Jesus
    Corral-Gudino, Luis
    Piedad Del-Amo-Merino, Maria
    Maria Eiros-Bouza, Jose
    Dominguez-Gil Gonzalez, Marta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 113 - 115
  • [50] Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
    Pokryszka, Jagoda
    Wagner, Angelika
    Wiedermann, Ursula
    Tobudic, Selma
    Herkner, Harald
    Winkler, Stefan
    Brehovsky, Sonja
    Reinisch, Walter
    Novacek, Gottfried
    VACCINES, 2022, 10 (05)